• Sebia

  • Dilva Martins Teixeira

Dilva Martins Teixeira

Regulatory Affairs Engineer at Sebia

Dilva Martins Teixeira is a Regulatory Affairs Engineer with a focus on the registration and renewal of In Vitro Diagnostic Medical Devices across the APAC region and Europe, currently working at SEBIA since January 2024. Prior experience includes roles as a Regulatory Affairs Consulting Engineer at ALTOGEN and Project Registration Specialist at STAGO, where responsibilities encompassed project management and change control under Regulation (EU) 2017/746. Earlier positions involved a Project Registration internship focused on writing technical files and updating procedures. Additional experience includes research roles at Gustave Roussy and the Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges, along with a developmental internship at CEBAL. Education includes a diploma in Biomedical Engineering and Health from EPISEN - ISBS and a DUT in Biological Engineering from IUT de Créteil-Vitry.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Sebia

2 followers

Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.


Headquarters

Lisses, France

Employees

1,001-5,000

Links